Candel Therapeutics, Inc. (CADL) vs OmniAb, Inc. (OABI)
- Candel Therapeutics, Inc. CADL 8.19 −8.08%
- OmniAb, Inc. OABI 4.59 −2.96%
Candel Therapeutics, Inc. and OmniAb, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and OmniAb, Inc. are of similar size ($687.7M and $681.8M). OmniAb, Inc. grew revenue faster over the last twelve months: 67.0% against 0.00%. Candel Therapeutics, Inc. has the higher net margin (0.00% vs −115.1%) and the higher return on invested capital (0.00% vs −14.5%). Across the 17 metrics below, OmniAb, Inc. leads on 11 and Candel Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | CADL | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 98.28% | 65.16% |
| Operating margin | 0.00% | (125.78%) | 0.00% |
| Net margin | 0.00% | (115.12%) | 0.00% |
| Free cash flow margin | 0.00% | (47.17%) | 0.00% |
| Return on equity | (81.84%) | (16.95%) | (56.36%) |
| Return on assets | (56.37%) | (15.11%) | (48.04%) |
| Return on invested capital | 0.00% | (14.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack